Back to Search
Start Over
1.5 Efficacy and Safety of Dulaglutide vs. Metformin in Type 2 Diabetes (AWARD-3) (69-OR)
- Source :
- Nederlands Tijdschrift voor Diabetologie. 11:78-78
- Publication Year :
- 2013
- Publisher :
- Springer Science and Business Media LLC, 2013.
-
Abstract
- This Phase 3, randomized, double-blind, parallel-arm, monotherapy study compared the efficacy and safety of 2 doses of dulaglutide (DU), a long-acting GLP-1-receptor agonist, to metformin (MET) in patients with early type 2 diabetes (mean 2.6 years) treated with diet and exercise alone or in combination with 1 oral antidiabetic medication (low dose for ≥ 3 months before screening).
Details
- ISSN :
- 18766242 and 15672743
- Volume :
- 11
- Database :
- OpenAIRE
- Journal :
- Nederlands Tijdschrift voor Diabetologie
- Accession number :
- edsair.doi...........a48eaba7a29fce764595c17d97a80849
- Full Text :
- https://doi.org/10.1007/s12467-013-0030-x